(Q48540910)

12 February 2018

title

Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis. (English)

1 reference

12 February 2018

0 references

3

Glenn Wylie

1 reference

12 February 2018

author name string

James F Sumowski

series ordinal

1

1 reference

12 February 2018

Nancy Chiaravalloti

series ordinal

2

1 reference

12 February 2018

John Deluca

series ordinal

4

1 reference

12 February 2018

publication date

1 July 2009

1 reference

12 February 2018

Journal of the International Neuropsychological Society

published in

1 reference

12 February 2018

volume

15

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

page(s)

606-612

1 reference

12 February 2018

Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Brain networks associated with cognitive reserve in healthy young and old adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

What is cognitive reserve? Theory and research application of the reserve concept

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS1355617709090912

21 January 2018

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

The measurement and clinical relevance of brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Education modifies the relation of AD pathology to level of cognitive function in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Depression in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Minimal neuropsychological assessment of MS patients: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Influence of leisure activity on the incidence of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Guidelines for neuropsychological research in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Distinct mechanisms of altered brain activation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

An investigation of working memory rehearsal in multiple sclerosis using fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Measurements of the normal ventricular system and hemispheric sulci of 100 adults with computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Education and the cognitive decline associated with MRI-defined brain infarct

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Influence of education on the relationship between white matter lesions and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Leisure activities and the risk of dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Functional magnetic resonance imaging response to increased verbal working memory demands among patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Cognitive reserve and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

Thalamic atrophy and cognition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Intelligence and neural efficiency

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Brain activation patterns associated with working memory in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709090912

7 January 2021

10.1017/S1355617709090912

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018